Search research articles
Contact Us
Filters
Showing results (781-790 of 889) with videos related to
Page
of 89
Sort By:
Blood
|
May 7, 2014
Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality
Mohamed L Sorror, Paul J Martin, Rainer F Storb, et al.
Sleep Medicine
|
February 21, 2017
The association between chronotype and sleep problems in preschool children
Nur K Jafar, Elaine K H Tham, Derric Z H Eng, et al.
Cancer Immunology Research
|
January 17, 2014
Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I
Aude G Chapuis, Olga K Afanasiev, Jayasri G Iyer, et al.
Blood Advances
|
November 17, 2022
Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL
Solomon A Graf, Ryan C Lynch, Chaitra S Ujjani, et al.
Science Signaling
|
March 18, 2025
Structural analysis reveals how tetrameric tyrosine-phosphorylated STAT1 is targeted by the rabies virus P-protein
Aoi Sugiyama, Miku Minami, Kaito Ugajin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 12, 2010
Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbidities
Hesham Eissa, Ted A Gooley, Mohamed L Sorror, et al.
The Lancet. Haematology
|
November 1, 2019
Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study
Effie W Petersdorf, Mary Carrington, Colm O'hUigin, et al.
British Journal of Haematology
|
January 1, 2019
Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial
Lihua E Budde, David Wu, Daniel B Martin, et al.
Cell Host & Microbe
|
December 15, 2015
Regulation of Starch Stores by a Ca(2+)-Dependent Protein Kinase Is Essential for Viable Cyst Development in Toxoplasma gondii
Alessandro D Uboldi, James M McCoy, Martin Blume, et al.
Blood
|
July 18, 2025
RGI-2001 for the Prophylaxis of Acute Graft-Versus-Host Disease Following Allogeneic HCT
Zachariah DeFilipp, Hannah K Choe, Yvonne A Efebera, et al.
Page
of 89
Search research articles
Search
Showing results (781-790 of 889) with videos related to
Sort By:
Page
of 89
Blood
|
May 7, 2014
Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality
Mohamed L Sorror, Paul J Martin, Rainer F Storb, et al.
Sleep Medicine
|
February 21, 2017
The association between chronotype and sleep problems in preschool children
Nur K Jafar, Elaine K H Tham, Derric Z H Eng, et al.
Cancer Immunology Research
|
January 17, 2014
Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I
Aude G Chapuis, Olga K Afanasiev, Jayasri G Iyer, et al.
Blood Advances
|
November 17, 2022
Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL
Solomon A Graf, Ryan C Lynch, Chaitra S Ujjani, et al.
Science Signaling
|
March 18, 2025
Structural analysis reveals how tetrameric tyrosine-phosphorylated STAT1 is targeted by the rabies virus P-protein
Aoi Sugiyama, Miku Minami, Kaito Ugajin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 12, 2010
Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbidities
Hesham Eissa, Ted A Gooley, Mohamed L Sorror, et al.
The Lancet. Haematology
|
November 1, 2019
Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study
Effie W Petersdorf, Mary Carrington, Colm O'hUigin, et al.
British Journal of Haematology
|
January 1, 2019
Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial
Lihua E Budde, David Wu, Daniel B Martin, et al.
Cell Host & Microbe
|
December 15, 2015
Regulation of Starch Stores by a Ca(2+)-Dependent Protein Kinase Is Essential for Viable Cyst Development in Toxoplasma gondii
Alessandro D Uboldi, James M McCoy, Martin Blume, et al.
Blood
|
July 18, 2025
RGI-2001 for the Prophylaxis of Acute Graft-Versus-Host Disease Following Allogeneic HCT
Zachariah DeFilipp, Hannah K Choe, Yvonne A Efebera, et al.
Page
of 89